VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 20 filers reported holding VASCULAR BIOGENICS LTD in Q4 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $15,398 | -69.2% | 128,318 | -60.1% | 0.00% | – |
| Q3 2022 | $50,000 | -91.4% | 321,876 | -11.4% | 0.00% | – |
| Q2 2022 | $584,000 | +138.4% | 363,135 | +150.3% | 0.00% | – |
| Q1 2022 | $245,000 | -24.4% | 145,096 | -11.6% | 0.00% | – |
| Q4 2021 | $324,000 | -49.8% | 164,104 | -48.0% | 0.00% | – |
| Q3 2021 | $646,000 | +14.7% | 315,313 | +33.8% | 0.00% | – |
| Q2 2021 | $563,000 | +310.9% | 235,651 | +244.0% | 0.00% | – |
| Q1 2021 | $137,000 | +522.7% | 68,500 | +480.5% | 0.00% | – |
| Q4 2020 | $22,000 | +57.1% | 11,800 | +10.3% | 0.00% | – |
| Q1 2020 | $14,000 | -6.7% | 10,700 | -32.2% | 0.00% | – |
| Q4 2018 | $15,000 | -50.0% | 15,776 | -15.6% | 0.00% | – |
| Q3 2018 | $30,000 | -14.3% | 18,684 | +18.2% | 0.00% | – |
| Q2 2018 | $35,000 | -80.9% | 15,802 | -80.1% | 0.00% | – |
| Q1 2018 | $183,000 | +128.8% | 79,557 | +604.0% | 0.00% | – |
| Q4 2017 | $80,000 | +29.0% | 11,300 | -0.1% | 0.00% | – |
| Q1 2017 | $62,000 | – | 11,309 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 2,593,286 | $4,382,000 | 1.02% |
| Telemetry Investments, L.L.C. | 75,000 | $127,000 | 0.20% |
| Ikarian Capital, LLC | 830,747 | $1,404,000 | 0.18% |
| DLD Asset Management, LP | 550,000 | $930,000 | 0.06% |
| Phoenix Holdings Ltd. | 1,020,000 | $1,724,000 | 0.03% |
| Spectrum Planning & Advisory Services Inc. | 16,000 | $27,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 79,716 | $135,000 | 0.00% |
| HBK Sorce Advisory LLC | 22,325 | $38,000 | 0.00% |
| B. Riley Wealth Management, Inc. | 12,000 | $20,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 12,155 | $21,000 | 0.00% |